Download the Free Prime PubMed App to your smartphone or tablet.

Available for iPhone or iPad:

Unbound PubMed app for iOS iPhone iPadAlso Available:
Unbound PubMed app for Android

Available for Mac and Windows Desktops and laptops:

Unbound PubMed app for WindowsUnbound PubMed app for MAC OS Yosemite Macbook Air pro
(American Journal of Obstetrics Gynecology[TA])
40,015 results
  • Levonorgestrel Intrauterine System associated amenorrhea: a systematic review and meta-analysis. [Review]
  • AJAm J Obstet Gynecol 2018 Dec 07
  • Sergison JE, Maldonado LY, … Hubacher D
  • CONCLUSIONS: Nearly 20% of LNG-IUS users experience amenorrhea during at least one 90-day interval by the first-year post-insertion. This composite estimate is consistent with the product labeling and demonstrates most users do not experience amenorrhea during the first year. These results provide accurate summary measures to facilitate counselling and informed method selection.
  • Cerclage for women with twin pregnancies: a systematic review and meta-analysis. [Review]
  • AJAm J Obstet Gynecol 2018 Dec 07
  • Li C, Shen J, Hua K
  • CONCLUSIONS: Our meta-analysis indicates that cerclage placement is beneficial for the reduction of PTB and the prolongation of pregnancy in twin pregnancies with a CL < 15 mm or dilated cervix > 10 mm. However, the benefit of history-indicated or twin alone-indication cerclage is less certain in twin pregnancies with normal CL according to current literature. Further high-quality studies were needed to confirm the findings.
  • Vascular and metabolic profiles in offspring born to pregnant mice with metabolic syndrome treated with inositols. [Journal Article]
  • AJAm J Obstet Gynecol 2018 Dec 03
  • Longo M, Alrais M, … Sibai BM
  • CONCLUSIONS: Inositols supplementation improved glucose tolerance, SBP and vascular responses in adult eNOS+/- and WT offspring born to dams with MS. Interestingly, WT born to MS dams show an altered vascular profile similar to eNOS+/- offspring and exhibit an improved response to INOs treatment. Our findings suggest that the benefits of INOs treatment are more pronounced in offspring exposed to environmental factors in utero, and less likely in those due to genetic factors.
New Search Next